Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026)

Xencor's (XNCR) quarterly Change in Acquisitions & Divestments came in at $100.0 million in Q1 2026, down 15.98% year-on-year from $119.0 million in Q1 2025, and up 14.9% on a QoQ basis from $87.0 million in Q4 2025.

Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $100.0 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 15.98% year-over-year to $100.0 million in Q1 2026; TTM through Mar 2026 was $386.1 million, a 44.77% decrease from a year earlier, with the FY2025 full-year figure at $405.1 million, down 31.35% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $100.0 million, up from $87.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for XNCR reached as high as $471.7 million in Q3 2024 and fell as low as -$339.6 million in Q3 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $73.0 million across 5 years, with a median of $87.0 million in 2025.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 1093.55% in 2025 and fell as far as 1741.72% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at -$205.3 million in 2022, then plunged by 65.41% to -$339.6 million in 2023, then soared by 133.61% to $114.1 million in 2024, then declined by 23.78% to $87.0 million in 2025, then climbed by 14.9% to $100.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $100.0 million in Q1 2026, $87.0 million in Q4 2025, and $304.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Xencor 1.49 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 99.97 Mn
Mar 31, 2026 99.97 Mn
Dec 31, 2025 87.00 Mn
Dec 31, 2025 87.00 Mn
Sep 30, 2025 304.69 Mn
Sep 30, 2025 304.69 Mn
Jun 30, 2025 -105.59 Mn
Jun 30, 2025 -105.59 Mn
Mar 31, 2025 118.99 Mn
Mar 31, 2025 118.99 Mn
Dec 31, 2024 114.14 Mn
Dec 31, 2024 114.14 Mn
Sep 30, 2024 471.67 Mn
Sep 30, 2024 471.67 Mn
Jun 30, 2024 -5.73 Mn
Jun 30, 2024 -5.73 Mn
Mar 31, 2024 9.97 Mn
Mar 31, 2024 9.97 Mn
Sep 30, 2023 -339.58 Mn
Sep 30, 2023 -339.58 Mn